Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more



Napp Pharmaceuticals

Drug combo device now also approved for asthma in childrenSubscription

14 January, 2019 By

Drug regulators have approved a combination of fluticasone and formoterol in a device that can be used with a spacer for treating asthma in children.

How to contact the news team

If you have a story you think may be of interest, please email Nursing Times editor Steve Ford at or senior reporter Gemma Mitchell at